SecBot SecBot
8-K ·Filed Oct 26, 2026

MIRM

Mirum Pharmaceuticals, Inc.
BULLISH
Impact 6/10
Processed3h 22m ago SEC0001759425-26-000054
8-K context-dependent: Items 8.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001759425-26-000054
Document: 0001759425-26-000054-index-headers.html0001759425-26-000054
Document: 0001759425-26-000054-index.html0001759425-26-000054
Document: 0001759425-26-000054.txt0001759425-26-000054
19 reports for MIRM
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 6 of 7 best @ T+20▲ +28.29%Jun 11, 2026
Filters
Rows
Reports for MIRM — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
BULLISH ★ 6/10
—awaiting T+60——
Oct 13, 2026
13d ago
8-K
BULLISH ★ 7/10
$79.62awaiting T+60—$80.39 (+0.97%)
Sep 28, 2026
28d ago
8-K
BULLISH ★ 7/10
$87.96awaiting T+60—$80.39 (−8.61%)
Aug 19, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$97.18awaiting T+60—$80.39 (−17.28%)
Aug 12, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$98.77awaiting T+60—$80.39 (−18.61%)
Aug 11, 2026
10w ago
Insider Cluster
BEARISH ★ 5/10
$98.97awaiting T+60—$80.39 (+18.77%)
Aug 10, 2026
11w ago
144
NEUTRAL ★ 3/10
$98.23awaiting T+60—$80.39 (−18.16%)
Aug 5, 2026
11w ago
8-K
MIXED ★ 6/10
$94.12awaiting T+60—$80.39 (−14.58%)
Jul 8, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$127.70 $82.93▼ −35.06%▼ −37.44%$80.39 (−37.05%)
Jun 11, 2026
19w ago
Institutional Cluster
BULLISH ★ 6/10
$99.54 $100.90▲ +1.37%▼ −3.03%$80.39 (−19.24%)
Showing 10 of 19

US Market Status

Market Closed — Opens Wed (13h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh MIRM Intelligence

Analysis is for subscribers only.

Subscribe for Full Access